BLCM Annual EBIT
-$26.98 M
-$2.59 M-10.63%
31 December 2022
Summary:
As of February 5, 2025, BLCM annual earnings before interest & taxes is -$26.98 million, with the most recent change of -$2.59 million (-10.63%) on December 31, 2022. During the last 3 years, it has risen by +$81.22 million (+75.06%).BLCM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLCM Quarterly EBIT
-$774.00 K
+$6.29 M+89.05%
01 September 2023
Summary:
As of February 5, 2025, BLCM quarterly earnings before interest & taxes is -$774.00 thousand, with the most recent change of +$6.29 million (+89.05%) on September 1, 2023. Over the past year, it has increased by +$6.39 million (+89.20%).BLCM Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLCM TTM EBIT
-$23.83 M
+$6.39 M+21.15%
01 September 2023
Summary:
As of February 5, 2025, BLCM TTM earnings before interest & taxes is -$23.83 million, with the most recent change of +$6.39 million (+21.15%) on September 1, 2023. Over the past year, it has increased by +$7.97 million (+25.07%).BLCM TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLCM EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -10.6% | +89.2% | +25.1% |
| 3 y3 years | +75.1% | -377.8% | +54.2% |
| 5 y5 years | +69.4% | +96.6% | +78.0% |
BLCM EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +746.1% | -104.1% | -453.6% |
Bellicum Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$774.00 K(-89.0%) | -$23.83 M(-21.2%) |
| June 2023 | - | -$7.07 M(-18.3%) | -$30.22 M(+1.8%) |
| Mar 2023 | - | -$8.64 M(+17.8%) | -$29.69 M(+10.0%) |
| Dec 2022 | -$26.98 M(+10.6%) | -$7.34 M(+2.4%) | -$26.98 M(-15.1%) |
| Sept 2022 | - | -$7.17 M(+9.6%) | -$31.80 M(+35.9%) |
| June 2022 | - | -$6.54 M(+10.1%) | -$23.40 M(+22.7%) |
| Mar 2022 | - | -$5.94 M(-51.1%) | -$19.06 M(-21.8%) |
| Dec 2021 | -$24.39 M(+381.7%) | -$12.16 M(-1085.9%) | -$24.39 M(-461.9%) |
| Sept 2021 | - | $1.23 M(-156.0%) | $6.74 M(+26.1%) |
| June 2021 | - | -$2.20 M(-80.5%) | $5.34 M(-115.3%) |
| Mar 2021 | - | -$11.26 M(-159.4%) | -$34.89 M(+588.9%) |
| Dec 2020 | -$5.06 M(-95.3%) | $18.97 M(<-9900.0%) | -$5.06 M(-90.3%) |
| Sept 2020 | - | -$162.00 K(-99.6%) | -$51.97 M(-37.2%) |
| June 2020 | - | -$42.43 M(-328.6%) | -$82.76 M(+25.1%) |
| Mar 2020 | - | $18.56 M(-166.4%) | -$66.18 M(-38.8%) |
| Dec 2019 | -$108.20 M(+15.3%) | -$27.94 M(-9.7%) | -$108.20 M(+1.7%) |
| Sept 2019 | - | -$30.95 M(+19.8%) | -$106.39 M(+8.4%) |
| June 2019 | - | -$25.85 M(+10.2%) | -$98.18 M(+2.8%) |
| Mar 2019 | - | -$23.46 M(-10.2%) | -$95.46 M(+1.7%) |
| Dec 2018 | -$93.84 M | -$26.13 M(+14.9%) | -$93.84 M(+5.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$22.74 M(-1.7%) | -$88.66 M(+0.4%) |
| June 2018 | - | -$23.13 M(+5.9%) | -$88.34 M(-0.4%) |
| Mar 2018 | - | -$21.84 M(+4.2%) | -$88.69 M(+0.7%) |
| Dec 2017 | -$88.11 M(+30.6%) | -$20.95 M(-6.5%) | -$88.11 M(+1.9%) |
| Sept 2017 | - | -$22.42 M(-4.5%) | -$86.45 M(+6.4%) |
| June 2017 | - | -$23.48 M(+10.5%) | -$81.24 M(+10.1%) |
| Mar 2017 | - | -$21.25 M(+10.1%) | -$73.78 M(+9.3%) |
| Dec 2016 | -$67.48 M(+39.0%) | -$19.30 M(+12.2%) | -$67.48 M(+4.5%) |
| Sept 2016 | - | -$17.20 M(+7.4%) | -$64.59 M(+5.9%) |
| June 2016 | - | -$16.02 M(+7.2%) | -$61.00 M(+9.9%) |
| Mar 2016 | - | -$14.95 M(-8.9%) | -$55.51 M(+14.9%) |
| Dec 2015 | -$48.54 M(-40.9%) | -$16.41 M(+20.5%) | -$48.31 M(-53.7%) |
| Sept 2015 | - | -$13.62 M(+29.3%) | -$104.45 M(+10.0%) |
| June 2015 | - | -$10.53 M(+35.8%) | -$94.92 M(+8.3%) |
| Mar 2015 | - | -$7.76 M(-89.3%) | -$87.66 M(+6.7%) |
| Dec 2014 | -$82.17 M(+937.8%) | -$72.55 M(+1675.9%) | -$82.17 M(+578.6%) |
| Sept 2014 | - | -$4.08 M(+24.9%) | -$12.11 M(+50.9%) |
| June 2014 | - | -$3.27 M(+43.8%) | -$8.02 M(+68.8%) |
| Mar 2014 | - | -$2.27 M(-8.3%) | -$4.75 M(+91.7%) |
| Dec 2013 | -$7.92 M(+26.5%) | -$2.48 M | -$2.48 M |
| Dec 2012 | -$6.26 M | - | - |
FAQ
- What is Bellicum Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Bellicum Pharmaceuticals?
- What is Bellicum Pharmaceuticals annual EBIT year-on-year change?
- What is Bellicum Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Bellicum Pharmaceuticals?
- What is Bellicum Pharmaceuticals quarterly EBIT year-on-year change?
- What is Bellicum Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Bellicum Pharmaceuticals?
- What is Bellicum Pharmaceuticals TTM EBIT year-on-year change?
What is Bellicum Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of BLCM is -$26.98 M
What is the all time high annual EBIT for Bellicum Pharmaceuticals?
Bellicum Pharmaceuticals all-time high annual earnings before interest & taxes is -$3.19 M
What is Bellicum Pharmaceuticals annual EBIT year-on-year change?
Over the past year, BLCM annual earnings before interest & taxes has changed by -$2.59 M (-10.63%)
What is Bellicum Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of BLCM is -$774.00 K
What is the all time high quarterly EBIT for Bellicum Pharmaceuticals?
Bellicum Pharmaceuticals all-time high quarterly earnings before interest & taxes is $18.97 M
What is Bellicum Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, BLCM quarterly earnings before interest & taxes has changed by +$6.39 M (+89.20%)
What is Bellicum Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of BLCM is -$23.83 M
What is the all time high TTM EBIT for Bellicum Pharmaceuticals?
Bellicum Pharmaceuticals all-time high TTM earnings before interest & taxes is $6.74 M
What is Bellicum Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, BLCM TTM earnings before interest & taxes has changed by +$7.97 M (+25.07%)